1. Introduction {#sec1}
===============

Hypertension might originate during early life. Maternal malnutrition can impair development, resulting in intrauterine growth restriction (IUGR), permanent structural changes, and disrupted physiological function---a phenomenon called "developmental programming" \[[@B1]\]. In the kidneys of both humans and experimental models, developmental programming reduces nephron numbers, alters the renin-angiotensin system (RAS), and impairs natriuresis, leading to adult kidney disease and hypertension \[[@B2]--[@B5]\].

A number of hypotheses have been proposed to explain the developmental programming phenomenon \[[@B6]\]. Oxidative stress is proposed as the underlying link between developmental programing and elevated risks of hypertension and kidney disease in adulthood \[[@B7], [@B8]\]. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase (NOS), causes oxidative stress and is involved in the development of hypertension \[[@B9]\]. Our recent work demonstrated that an impaired ADMA-NO pathway and low nephron numbers are associated with programmed hypertension in the adult offspring of malnourished or diabetic mothers \[[@B10], [@B11]\]. Reduced nephron numbers impaired renal tubular sodium reabsorption, and the altered RAS components disrupted sodium retention, ultimately increasing blood pressure (BP) and inducing kidney damage. Histone deacetylases (HDACs) repress gene expression, a mechanism of epigenetic control that is involved in developmental programming. Class I HDACs are critical in nephrogenesis, particularly HDAC1-3 that are highly expressed in nephron precursors \[[@B12]\]. HDACs also play an important role in regulating RAS components during nephrogenesis \[[@B13]\]. These observations suggest that these mechanisms jointly lead to the development of hypertension and kidney disease.

Melatonin, an indoleamine produced from the pineal gland, is an antioxidant and free radical scavenger \[[@B14]\]. Experimental and human studies indicate that melatonin can regulate BP \[[@B10], [@B11]\]. We recently found that melatonin can prevent oxidative stress and hypertension concurrently in young spontaneously hypertensive rats (SHR) \[[@B15]\]. Emerging evidence supports novel roles of melatonin in epigenetic modulation through the regulation of HDACs \[[@B16], [@B17]\]. Thus, we examined whether melatonin prevented programmed hypertension in offspring exposed to maternal caloric restriction through reduction of oxidative stress, alteration of the RAS pathway, and modulation of HDACs. Moreover, we identified melatonin-induced gene changes during nephrogenesis and determined whether melatonin treatment induced global changes in biological processes by using next-generation sequencing.

2. Material and Methods {#sec2}
=======================

2.1. Animal Models {#sec2.1}
------------------

This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the Kaohsiung Chang Gung Memorial Hospital. Virgin Sprague-Dawley (SD) rats (12--16 weeks old) were obtained from BioLASCO Taiwan Co., Ltd. (Taipei, Taiwan), and were housed and maintained in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. Male SD rats were caged with individual females until mating was confirmed. Calorie-restricted (CR) maternal rats received 11 g/d of a standard chow from day 11 of pregnancy until the day of delivery (day 23) and 20 g/d during the entire lactation period \[[@B10]\]. A subset of CR mothers was treated for the duration of the pregnancy with 0.01% melatonin dissolved in drinking water (CR + M, *n* = 8). The control group (*n* = 8) mothers had free access to standard rat chow. As another control, maternal rats were allowed free access to standard rat chow and were treated with 0.01% melatonin in drinking water (M, *n* = 10). After birth, each litter was left with the mother until weaning; pups were not weighed at birth to prevent maternal rejection. Male offspring, selected at random from each litter, were used in all subsequent experiments. In rats, nephrogenesis occurs predominantly from late gestation to 1-2 weeks postnatum and litters were typically weaned by postnatal week 3. Thus, melatonin was administered to mother rats for a total period of 6 weeks to cover the entire period of nephrogenesis. The dose of melatonin used was based on our previous study \[[@B15]\]. Water bottles were covered with aluminum foil to protect them from light. BP was measured in conscious rats by using an indirect tail-cuff method (BP-2000, Visitech Systems, Inc., Apex, NC, USA) after they had been systematically trained \[[@B10]\]. Three stable consecutive measures were taken and averaged. All offspring were sacrificed at 12 weeks of age and heparinized blood samples were collected. Kidneys were harvested after perfusion with PBS, divided into cortex and medulla regions, and snap-frozen. The activity of dimethylarginine dimethylaminohydrolase (DDAH), an ADMA-metabolizing enzyme, was measured using a colorimetric assay. The assay determined the rate of[l]{.smallcaps}-citrulline production and we performed the assay as previously described \[[@B18]\].

2.2. High-Performance Liquid Chromatography (HPLC) {#sec2.2}
--------------------------------------------------

Plasma and kidney[l]{.smallcaps}-arginine,[l]{.smallcaps}-citrulline, ADMA, and symmetric dimethylarginine (SDMA, a stereoisomer of ADMA) levels were measured using HPLC (HP series 1100, Agilent Technologies, Inc., Santa Clara, CA, USA) with the OPA-3MPA derivatization reagent as we described previously \[[@B10]\]. Standards contained[l]{.smallcaps}-arginine,[l]{.smallcaps}-citrulline, ADMA, and SDMA in the range of 1--100 *μ*M, 1--100 *μ*M, 0.5--5 *μ*M, and 0.5--5 *μ*M, respectively. The recovery rate was between 90 and 105%. The tissue concentration was factored for protein concentration, which was represented as *μ*mol/mg protein. Plasma and urine creatinine (Cr) levels were analyzed by HPLC as described previously \[[@B10]\]. The creatinine clearance (CCr) was calculated by dividing the total amount of Cr excreted in urine by the Cr concentration in plasma. CCr values were normalized with respect to body weight.

2.3. Electron Paramagnetic Resonance (EPR) {#sec2.3}
------------------------------------------

Superoxide production was measured by EPR spectroscopy using a 1-hydroxy-3-carboxypyrrolidine (CPH) hydroxylamine spin probe, as we previously described \[[@B11]\]. The EPR spectra were recorded using an EMX Plus EPR spectrometer (Bruker BioSpin, Rheinstetten, Germany) equipped with an EMX-m40X microwave bridge operating at 9.87 GHz. NO was detected by EPR using N-methyl-D-glucamine dithiocarbamate (MGD) spin probe and FeSO~4~, as previously described \[[@B11]\]. The EPR spectra were recorded using an EMX Plus EPR spectrometer (Bruker BioSpin) equipped with an EMX-m40X microwave bridge operating at 3.16 GHz.

2.4. Metanephros Organ Culture {#sec2.4}
------------------------------

Metanephros organ culture was performed as we described previously \[[@B11]\]. Briefly, SD female rats of known mating date were anesthetized and laparotomized. Fetuses were aseptically removed, and metanephroi from fetuses at embryonic day 14 (E14) were collected and freed of exogenous tissue. Explants were placed onto a Steritop filter unit (Millipore, Billerica, MA, USA) floating on a defined serum-free medium and incubated for 6 d in 35 mm Petri dishes at 37°C in a humidified incubator (5% CO~2~). The defined medium was composed of Eagle\'s Minimum Essential Medium containing 10% (v/v) fetal calf serum, 100 units/mL penicillin, and 100 *μ*g/mL streptomycin. All of these reagents were obtained from Sigma (St. Louis, MO, USA). The culture medium was changed daily, and no antibiotic or fungicide was present throughout the experiment. Fresh aliquots of each culture medium additive were used for each metanephros culture. The medium was changed daily. Metanephroi were treated with melatonin (1 *μ*M and 1 mM) and harvested after 6 d for real-time polymerase chain reaction.

2.5. Quantitative Real-Time Polymerase Chain Reaction (PCR) {#sec2.5}
-----------------------------------------------------------

RNA was extracted as described previously \[[@B10]\]. Two-step quantitative real-time PCR was conducted using the QuantiTect SYBR Green PCR Kit (Qiagen, Valencia, CA, USA) and the iCycler iQ Multicolor Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). Nephron deficit was assessed by changes in the expression factors known to be involved in branching morphogenesis (BMP4, FGF2, and PAX2) and apoptosis (p53 and Bax). Several components of the RAS were analyzed including renin, prorenin receptor (PRR), angiotensinogen (AGT), angiotensin-converting enzyme (ACE), ACE2, angiotensin II type 1 (AT1R) and 2 receptor (AT2R), and angiotensin (1--7) MAS receptor. Class I HDACs, HDAC-1, -2, -3, and -8, were also examined. We used 18S rRNA (r18S) as a reference. Primers were designed using GeneTool Software (BioTools, Edmonton, Alberta, Canada) ([Table 1](#tab1){ref-type="table"}). All samples were run in duplicate. To quantify the relative gene expression, the comparative threshold cycle (C~T~) method was employed. For each sample, the average C~T~ value was subtracted from the corresponding average r18S value, calculating the ΔC~T~. ΔΔC~T~ was calculated by subtracting the average control ΔC~T~ value from the average experimental ΔC~T~. The fold-increase of the experimental sample relative to the control was calculated using the formula 2^−ΔΔC~T~^.

2.6. Western Blot {#sec2.6}
-----------------

Western blot analysis was performed as previously described \[[@B10]\]. We used the following antibodies from Santa Cruz Biotechnology (Santa Cruz, CA, USA): rabbit polyclonal anti-rat PRR (1 : 500, overnight incubation), rabbit anti-rat ACE2 (1 : 1000, overnight incubation), rabbit anti-rat AT1R (1 : 250, overnight incubation), rabbit anti-rat AT2R (1 : 250, overnight incubation), and rabbit anti-rat MAS (1 : 1000, overnight incubation; Santa Cruz Biotechnology). The bands of interest were visualized using enhanced chemiluminescence reagent (PerkinElmer, Waltham, MA, USA) and quantified by densitometry (Quantity One Analysis software, Bio-Rad). Band density was calculated as the integrated optical density (IOD) minus the background value. The density of Ponceau red staining (PonS) was used to correct for variations in total protein loading. Protein abundance was calculated as IOD/PonS.

2.7. Next-Generation Sequencing and Analysis {#sec2.7}
--------------------------------------------

In rats, nephrogenesis occurs predominantly from late gestation to 7--10 days postnatum. Thus, offspring from the control and M groups were sacrificed at 1 week of age. Kidneys were isolated and snap-frozen for whole-genome RNA next-generation sequencing (RNA-seq), performed by Welgene Biotech Co., Ltd. (Taipei, Taiwan). Purified RNA was quantified at 260 nm (OD~600~) by using ND-1000 spectrophotometer (Nanodrop Technology, Wilmington, DE, USA) and analyzed using a Bioanalyzer 2100 (Agilent Technology) with RNA 6000 LabChip kit (Agilent Technologies). All procedures were performed according to the Illumina protocol. For all samples, library construction was performed using the TruSeq RNA Sample Prep Kit v2 for ∼160 bp (single-end) sequencing and the Solexa platform. The sequence was directly determined by sequencing-by-synthesis technology using the TruSeq SBS Kit. Raw sequences were obtained using the Illumina GA Pipeline software CASAVA v1.8, which was expected to generate 10 million reads per sample. Quantification for gene expression was calculated as reads per kilobase of exon per million mapped reads \[[@B19]\]. For differential expression analysis, Cufflink v 2.1.1 and CummeRbund v 2.0.0 were used to perform statistical analyses of the gene expression profiles. The reference genome and gene annotations were retrieved from the Ensembl database (<http://asia.ensembl.org/index.html>). Gene ontology analysis for significant genes was performed using KEGG (<http://www.genome.jp/kegg/>) and NIH DAVID Bioinformatics Resources 6.7 (<http://david.abcc.ncifcrf.gov/>) to identify regulated biological themes.

2.8. Statistical Analysis {#sec2.8}
-------------------------

TheShapiro-Wilk normality test was used to determine which data were normally distributed. Normally distributed data are given as mean ± standard error of the mean. For most parameters, statistical analysis was performed using one-way analysis of variance (ANOVA) and Tukey\'s post hoc test for multiple comparisons. BP was analyzed by two-way repeated-measures ANOVA and Tukey\'s post hoc test. A *P* value \< 0.05 was considered statistically significant. Analyses were performed using the Statistical Package for the Social Sciences (SPSS) software (Chicago, IL, USA).

3. Results {#sec3}
==========

3.1. The Effects of Melatonin on Morphological and Biochemical Values in CR Rats {#sec3.1}
--------------------------------------------------------------------------------

Litter sizes were not significantly altered by caloric restriction in the mother rat or by melatonin treatment. The amounts of water intake and urine output were not significantly different in the control and CR groups. Male pup mortality rates did not differ between the four groups analyzed. As shown in [Table 2](#tab2){ref-type="table"}, the CR and M groups had lower and higher body weight (BW) than the control at 12 weeks of age, respectively, whereas the CR + M group had an intermediate BW. Kidney weight and kidney weight-to-BW ratio did not differ between the control and CR groups. Melatonin significantly increased kidney weight and kidney weight-to-BW ratio in the M and CR + M groups. Although heart weight was not different between control and CR groups, the heart weight-to-BW ratio was greater in the CR group. Melatonin caused increased heart weight and heart weight-to-BW ratio in the M group, but not in the CR + M group. CR increased systolic and diastolic BP and mean arterial pressure at 12 weeks of age. Melatonin therapy prevented these effects of CR. In addition, melatonin therapy reduced diastolic BP and mean arterial pressure in the M group compared to the control. As shown in [Figure 1](#fig1){ref-type="fig"}, mean arterial pressure was similar in the four groups at 4 weeks of age. By 8 weeks of age, mean arterial pressure had increased in the CR group relative to controls. A significant reduction in mean arterial pressure was measured in the M and CR + M groups versus the control at 8 and 12 weeks of age. In contrast, plasma creatinine level did not differ between the four groups. These data demonstrated that CR induced programmed hypertension but had no effect on renal function on 12-week-old offspring.

3.2. The Effects of Melatonin on[l]{.smallcaps}-Arginine,[l]{.smallcaps}-Citrulline, and Dimethylarginine Levels {#sec3.2}
----------------------------------------------------------------------------------------------------------------

As shown in [Table 3](#tab3){ref-type="table"}, plasma levels of ADMA and SDMA were elevated nearly 70% and 150% following maternal CR, respectively. In contrast, the[l]{.smallcaps}-arginine levels and[l]{.smallcaps}-arginine-to-ADMA ratio were decreased by 30% and 55%, respectively. Melatonin treatment significantly increased[l]{.smallcaps}-arginine levels and[l]{.smallcaps}-arginine-to-ADMA ratio, but decreased ADMA and SDMA levels in the CR + M group. In the kidney, levels of[l]{.smallcaps}-citrulline,[l]{.smallcaps}-arginine, ADMA, and SDMA did not differ between the four groups. However, renal[l]{.smallcaps}-arginine-to-ADMA ratio was higher in the CR + M group versus the M group. We next analyzed superoxide and NO production in the kidney by using EPR. We found no difference in renal superoxide level among the four groups (control: 745 ± 28, CR: 823 ± 107, M: 665 ± 35, CR + M: 757 ± 42 arbitrary units; *P* \> 0.05). CR significantly reduced renal NO levels, but not in the presence of melatonin (control: 412 ± 43, CR: 284 ± 18, M: 308 ± 34, CR + M: 414 ± 55 arbitrary units; control versus CR, *P* \< 0.05; CR versus CR + M, *P* \< 0.05).

3.3. The Effects of Melatonin on the ADMA Pathway {#sec3.3}
-------------------------------------------------

Next, we examined the expression/activity of proteins involved in the ADMA pathway. We found that renal level of protein arginine N-methyltransferase 1 (PRMT-1), an ADMA-synthesizing enzyme, was significantly lower in the M and CR + M groups than that in control and CR groups ([Figure 2(b)](#fig2){ref-type="fig"}). However, protein levels of DDAH-1 and -2, ADMA-metabolizing enzymes, in the kidney were not different between the four groups (Figures [2(c)](#fig2){ref-type="fig"} and [2(d)](#fig2){ref-type="fig"}). We found that renal DDAH activity did not differ between control and CR groups ([Figure 2(e)](#fig2){ref-type="fig"}). However, melatonin increased renal DDAH activity in both the M and CR + M groups. Thus, we speculate that the increase of systemic ADMA observed with CR is due to excessive synthesis or decreased metabolism in extrarenal tissues. On the other hand, the reduced plasma ADMA levels in response to melatonin might be due to decreased ADMA synthesis and increased ADMA breakdown in the kidney.

3.4. The Effects of Melatonin on Nephrogenesis {#sec3.4}
----------------------------------------------

We investigated whether changes in nephrogenesis- or apoptosis-related gene expression were associated with CR-induced reduced nephron numbers, as we found previously \[[@B10]\]. Consistent with our previous report \[[@B10]\], renal expression of p53 and the proapoptotic factor Bax did not differ between the control and CR groups ([Figure 3(a)](#fig3){ref-type="fig"}). Similarly, growth factors BMP4 and FGF2 were unaltered by CR or melatonin in the kidney. However, melatonin significantly increased the expression of the transcriptional activator PAX2 in CR + M group compared to controls ([Figure 3(a)](#fig3){ref-type="fig"}).

3.5. The Effects of Melatonin on Sodium Transporters, RAS, and HDACs {#sec3.5}
--------------------------------------------------------------------

Next, we evaluated two critical pathways involved in hypertension, sodium transporters and RAS components. We found that CR upregulated sodium-hydrogen exchanger 3 (NHE3) expression in the kidney ([Figure 3(b)](#fig3){ref-type="fig"}). The increase in renal NHE3 expression was not prevented by melatonin therapy. CR had no effect on the expression of RAS genes in the kidney, including renin, PRR, AGT, ACE, ACE2, AT1R, AT2R, and MAS ([Figure 3(c)](#fig3){ref-type="fig"}). Melatonin treatment, on the other hand, upregulated renal expression of renin, PRR, and ACE2 in the CR + M group compared to the control. Because melatonin therapy prevented the elevation of BP in offspring exposed to maternal CR, our data suggested that the antihypertensive effect of melatonin was related to renin, PRR, and ACE2 expression in the CR model. We found that CR did not alter renal expression of class I HDACs in the CR versus control group ([Figure 3(d)](#fig3){ref-type="fig"}). However, melatonin therapy increased HDAC-2, -3, and -8 expression in the kidney.

We analyzed the renal protein levels of PRR, ACE2, AT1R, AT2R, and MAS. Melatonin therapy significantly increased renal PRR and ACE2 protein levels in the M and CR + M group compared with the control and CR groups (Figures [4(b)](#fig4){ref-type="fig"} and [4(c)](#fig4){ref-type="fig"}). We observed that renal AT1R, AT2R, and MAS protein levels did not differ among the four groups (Figures [4(d)](#fig4){ref-type="fig"}--[4(f)](#fig4){ref-type="fig"}).

We also determined whether melatonin regulated nephrogenesis-related genes, RAS components, sodium transporters, and HDACs during nephrogenesis. The mRNA levels in rat metanephroi grown in different concentrations of melatonin are shown in [Figure 5](#fig5){ref-type="fig"}. We found that low doses of melatonin had no effect on the expression of these genes, whereas high-dose melatonin treatment significantly increased expression of PAX2, renin, PRR, Mas, NHE3, and Na-K-Cl cotransporter 2 in metanephroi.

3.6. The Effects of Melatonin on Gene Expression during Nephrogenesis {#sec3.6}
---------------------------------------------------------------------

We demonstrated that numerous individual genes were significantly regulated in the kidneys of offspring from melatonin-treated mothers during a critical period of renal development. As shown in [Table 4](#tab4){ref-type="table"}, 439 and 15 genes were upregulated and downregulated, respectively. The most significantly regulated biological theme in the KEGG gene ontology analysis was tryptophan metabolism ([Figure 6](#fig6){ref-type="fig"}).

4. Discussion {#sec4}
=============

The major findings of our study can be summarized as follows: (1) CR offspring developed hypertension at 12 weeks of age and this was prevented by maternal melatonin therapy; (2) melatonin restored the CR-induced increase of plasma ADMA level, decreased[l]{.smallcaps}-arginine level, and decreased[l]{.smallcaps}-arginine-to-ADMA ratio; (3) CR reduced renal NO level and this was prevented by melatonin; (4) melatonin therapy increased PAX2 mRNA expression in the CR + M group; (5) CR upregulated renin and PRR expression and melatonin suppressed this increase; (6) melatonin therapy significantly increased renal ACE2 protein levels in the M and CR + M group; and (7) the expression of numerous genes was regulated in melatonin-treated offspring kidneys during nephrogenesis.

Our recent work indicates that ADMA-induced NO/reactive oxygen species (ROS) imbalance is involved in the development of hypertension in two different developmental models, maternal caloric restriction, and maternal diabetes \[[@B10], [@B11]\]. Several lines of evidence in this study indicated that ADMA-induced NO/ROS imbalance is involved in the developmental programming of hypertension in offspring exposed to maternal caloric restriction. First, plasma levels of the endogenous NOS inhibitor ADMA were increased in the CR group. Second, ADMA and[l]{.smallcaps}-arginine both compete for NOS and are present in a ratio that maintains NO homeostasis; this ratio was decreased in the plasma in the CR group. Third, maternal CR decreased renal NO levels in the offspring. Thus, alterations in the ADMA-NO pathway might be a major factor involved in programmed adult hypertension in response to maternal CR.

Melatonin is rapidly transferred from maternal to fetal circulation \[[@B20]\]. Administration of melatonin to pregnant rats prevents oxidative stress damage in the brains of offspring \[[@B21]\]. Previously, we showed that melatonin increases NO, restoring NO/ROS balance at the prehypertension stage and leading to lower blood pressure in young SHR \[[@B15]\]. Consistent with these findings, we found that early melatonin therapy in the mother could prevent programmed hypertension in their adult offspring. Thus, we suggest that melatonin has a novel protective effect on programmed hypertension through acting on the ADMA-NO pathway.

In addition to oxidative stress, the RAS plays a fundamental role in the development of hypertension and kidney development \[[@B5]\]. Epigenetic regulation of several RAS components has been reported in different programmed hypertension models \[[@B23], [@B24]\]. We demonstrated for the first time that melatonin therapy during nephrogenesis increased renin, PRR, and ACE2 expression in the kidney of the adult offspring. Consistent with these data, renal protein levels of PRR and ACE2 were increased in melatonin-treated offspring. Renin-PRR signaling is essential for proper kidney development and is causally linked to hypertension \[[@B13]\]. ACE2 appears to antagonize the effects of ACE through the production of angiotensin (1--7) in a manner that opposes the development of hypertension \[[@B25]\]. Surprisingly, melatonin therapy increased ACE2 expression in the kidney and prevented CR-induced programmed hypertension, despite the presence of increased renin and PRR expression. Notably, melatonin upregulated several RAS components and had reciprocal effects on vasodilation and vasoconstriction in rats at 3 months of age. Future studies are required to clarify the underlying mechanisms involved in the differential regulation of RAS components by melatonin.

Long-term amelioration of hypertension by melatonin therapy during gestation and lactation may be due to epigenetic changes in the kidney during a critical period of nephrogenesis. We found that melatonin upregulated HDAC-2, -3, and -8 expression in the kidney in CR + M group. This finding is consistent with that of our previous study showing that melatonin increased the expression of both class I and class II HDACs in vitro \[[@B26]\]. Given that melatonin increased class I HDACs expression and that HDACs are primarily thought to repress gene transcription, melatonin likely upregulates gene expression. Conversely, melatonin is known as a class III HDAC inhibitor \[[@B17]\]. Thus, melatonin might have dual effects on HDACs to epigenetically regulate gene expression. To the best of our knowledge, our study is the first to document altered expression of more than 400 genes in the kidney in response to melatonin and implicates melatonin in the protection from programmed hypertension in adult life. Notably, our data imply that melatonin is liable to induce, but not suppress, gene expression in the developing kidney. Using the KEGG database, several biological pathways were proposed to be regulated by melatonin including focal adhesion signaling, the peroxisome proliferator-activated receptors signaling pathway, fatty acid metabolism, the transforming growth factor *β* signaling pathway, and the Wnt signaling pathway. These findings suggest that melatonin might have a global epigenetic effect during nephrogenesis. Interestingly, the most significantly regulated biological theme was tryptophan metabolism, indicating that melatonin might have a negative feedback effect on its precursor tryptophan. Notably, maternal melatonin therapy has adverse effects on survival and renal growth in Wistar-Kyoto rats \[[@B27]\]. Because our data showed that maternal melatonin therapy had strong epigenetic effects, further evaluation is warranted to determine whether early melatonin therapy causes long-term epigenetic changes that lead to adverse effects in adulthood.

Previously, we showed that maternal CR reduces nephron numbers in offspring \[[@B10]\]. Increases in renal apoptosis and impaired expression of nephrogenesis-related genes may contribute to this reduction. In contrast to several earlier reports \[[@B28], [@B29]\], we found that apoptosis- and nephrogenesis-related genes were not altered in maternal CR-induced programmed hypertension. Of note, we showed for the first time that melatonin treatment upregulated PAX2 mRNA in metanephroi. Because PAX2 plays a crucial role in kidney development and is associated with various congenital renal and ureteral malformations, further studies are warranted to understand the epigenetic regulation of melatonin on PAX2 during nephrogenesis.

We conclude that prenatal melatonin therapy offsets the effects of maternal CR-induced programmed hypertension in adult offspring, primarily through the restoration of the ADMA-NO balance in the kidney. Our data suggested that a critical window exists during nephrogenesis in which the adult BP can be modified. Moreover, we showed that melatonin can modulate type I HDACs and serve as an inducer of gene expression in the developing kidney. The implications of melatonin-induced epigenetic changes on programmed hypertension in later life remain to be explored.
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![Effect of melatonin and caloric restriction (CR) on mean arterial pressure in male offspring at 12 weeks of age.  \**P* \< 0.05 versus control; ^\#^ *P* \< 0.05 versus CR.](OMCL2014-283180.001){#fig1}

![Representative western blots (a) showing protein arginine methyltransferase 1 (PRMT-1; ∼42 kDa), dimethylarginine dimethylaminohydrolase 1 (DDAH-1; ∼34 kDa), and DDAH-2 (∼30 kDa) bands in CR offspring at 12 weeks of age. Relative abundance of renal cortical (b) PRMT-1, (c) DDAH-1, and (d) DDAH-2. (e) Effect of melatonin and CR on renal DDAH activity in male offspring at 12 weeks of age. \**P* \< 0.05 versus control; ^\#^ *P* \< 0.05 versus CR.](OMCL2014-283180.002){#fig2}

![Effect of melatonin and CR on the expression of (a) apoptosis- and nephrogenesis-related genes, (b) sodium transporters, (c) renin-angiotensin system (RAS) components, and (d) class I histone deacetylase (HDAC) in the kidney at 12 weeks of age. \**P* \< 0.05 versus control; ^\#^ *P* \< 0.05 versus CR; ^\$^ *P* \< 0.05 versus M.](OMCL2014-283180.003){#fig3}

![Representative western blots (a) showing prorenin receptor (PRR; 39 kDa), angiotensin-converting enzyme (ACE2; 50 kDa), angiotensin II type 1 (AT1R; 43 kDa) and type 2 (AT2R; 90 kDa), and MAS (37 kDa) proteins in male offspring kidneys at 12 weeks of age. Relative abundance of renal (b) PRR, (c) ACE2, (d) AT1R, (e) AT2R, and (f) MAS is quantified. \**P* \< 0.05 versus control; ^\#^ *P* \< 0.05 versus CR.](OMCL2014-283180.004){#fig4}

![Gene expression of (a) apoptosis- and nephrogenesis-related genes, (b) RAS components, and (c) sodium transporters in the metanephroi of offspring from mothers treated with melatonin (1 *μ*M or 1 mM). \**P* \< 0.05 versus control (*n* = 5/group).](OMCL2014-283180.005){#fig5}

![Enzymes of the tryptophan metabolism pathway that are regulated by melatonin therapy in the kidney (red stars). Data were analyzed using the KEGG Pathway feature of the DAVID software.](OMCL2014-283180.006){#fig6}

###### 

PCR primers sequences.

  Gene                Forward                        Reverse
  ------------------- ------------------------------ -------------------------------
  Bax                 5 ttgctgatggcaacttcaactg 3     5 ctttagtgcacagggccttgag 3
  P53                 5 catgagcgttgctctgatg 3        5 cagatactcagcatacggatttcc 3
  PAX2                5 gagactcccagagtggtgtg 3       5 cattcccctgttctgatttg 3
  FGF2                5 ccagttggtatgtggcactg 3       5 cagggaagggtttgacaaga 3
  BMP4                5 gacttcgaggcgacacttctg 3      5 agccggtaaagatccctcatg 3
  Renin               5 aacattaccagggcaactttcact 3   5 acccccttcatggtgatctg 3
  Prorenin receptor   5 gaggcagtgaccctcaacat 3       5 ccctcctcacacaacaaggt 3
  Angiotensinogen     5 gcccaggtcgcgatgat 3          5 tgtacaagatgctgagtgaggcaa 3
  ACE                 5 caccggcaaggtctgctt 3         5 cttggcatagtttcgtgaggaa 3
  ACE2                5 acccttcttacatcagccctactg 3   5 tgtccaaaacctaccccacatat 3
  AT1R                5 gctgggcaacgagtttgtct 3       5 cagtccttcagctggatcttca 3
  AT2R                5 caatctggctgtggctgactt 3      5 tgcacatcacaggtccaaaga 3
  MAS                 5 catctctcctctcggctttgtg 3     5 cctcatccggaagcaaagg 3
  HDAC-1              5 gaactggggacctacggg 3         5 gctcttgacaaattccacacac 3
  HDAC-2              5 agttgcccttgattgtgaga 3       5 ccactgttgtccttggatttat 3
  HDAC-3              5 tgatgaccagagttacaagcac 3     5 gggcaacatttc ggacag 3
  HDAC-8              5 gctacccccggtttatatttacag 3   5 ttcgatcagagagtgaaccatactg 3
  R18S                5 gccgcggtaattccagctcca 3      5 cccgcccgctcccaagatc 3

###### 

Morphological and biochemical values in different experimental groups.

                                       Control       CR              M                  CR + M
  ------------------------------------ ------------- --------------- ------------------ -------------------
  Mortality                            10%           0%              0%                 0%
  Body weight (BW) (g)                 435 ± 14      356 ± 4\*       489 ± 8^∗\#^       370 ± 9^∗\$^
  Left kidney weight (g)               1.22 ± 0.06   1.01 ± 0.02     1.97 ± 0.05^∗\#^   1.48 ± 0.03^\#\$^
  Left kidney weight/100g BW           0.28 ± 0.01   0.28 ± 0.01     0.4 ± 0.01^∗\#^    0.4 ± 0.01^∗\#^
  Heart weight (g)                     1.23 ± 0.05   1.24 ± 0.02     1.63 ± 0.01^∗\#^   1.16 ± 0.05^\$^
  Heart weight/100 g BW                0.28 ± 0.01   0.35 ± 0.01\*   0.35 ± 0.01\*      0.31 ± 0.01
  Systolic blood pressure (mmHg)       162 ± 2       180 ± 2\*       155 ± 1^\#^        166 ± 1^\$^
  Diastolic blood pressure (mmHg)      122 ± 2       134 ± 3\*       108 ± 2^∗\#^       113 ± 1^∗\#^
  Mean arterial pressure (mmHg)        135 ± 2       149 ± 2\*       124 ± 1^∗\#^       131 ± 1^\#\$^
  CCr, mL·min^−1^·kg body weight^−1^   9.12 ± 3.45   8.5 ± 3.0       7.34 ± 2.32        7.81 ± 2.76

CCr: clearance of creatinine; \**P* \< 0.05 versus control; ^\#^ *P* \< 0.05 versus CR; ^\$^ *P* \< 0.05 versus M.

###### 

[L]{.smallcaps}-Citrulline, [L]{.smallcaps}-arginine, and dimethylarginine levels in the plasma and kidney.

                                             Control       CR              M                 CR + M
  ------------------------------------------ ------------- --------------- ----------------- ------------------
  Plasma (*μ*mol)                                                                             
    [L]{.smallcaps}-Citrulline               50 ± 4.1      61 ± 3.6        59.3 ± 5.1        55.8 ± 6.9
    [L]{.smallcaps}-Arginine                 121.1 ± 14    84.4 ± 2.4\*    113.6 ± 8.7^\#^   112.8 ± 13.6^\#^
   ADMA                                      1.31 ± 0.1    2.21 ± 0.18\*   1.18 ± 0.06^\#^   1.08 ± 0.12^\#^
   SDMA                                      0.66 ± 0.04   1.62 ± 0.27\*   0.97 ± 0.09^\#^   0.92 ± 0.08^\#^
    [L]{.smallcaps}-Arginine-to-ADMA ratio   92 ± 8        40 ± 4\*        98 ± 10^\#^       105 ± 6^\#^
  Kidney (*μ*mol/mg protein)                                                                  
    [L]{.smallcaps}-Citrulline               52.5 ± 8.6    53.1 ± 4.6      97.6 ± 8.4        68.8 ± 12.4
    [L]{.smallcaps}-Arginine                 425 ± 62.3    552.9 ± 58.9    522.8 ± 61.6      488.1 ± 56
   ADMA                                      5.09 ± 0.88   6.33 ± 0.71     6.72 ± 1.03       4.84 ± 0.61
   SDMA                                      4.3 ± 0.65    5.3 ± 0.51      5.57 ± 0.79       4.59 ± 0.73
    [L]{.smallcaps}-Arginine-to-ADMA ratio   86 ± 4        89 ± 5          80 ± 4            103 ± 8^\$^

\**P* \< 0.05 versus control; ^\#^ *P* \< 0.05 versus CR; ^\$^ *P* \< 0.05 versus M.

###### 

Genes that changed by RPKM \> 0.3 in the kidney of melatonin treated offspring versus control at 1 week of age.

  Gene_ID                    Gene symbol    Fold changes   Log~2~   *P* value
  -------------------------- -------------- -------------- -------- -----------
  Upregulated: 439 genes                                            
  ENSRNOG00000038989         D3ZSD6_RAT     28.686         4.842    0.0083
  ENSRNOG00000006367         Slc5a8         19.264         4.268    0.0001
  ENSRNOG00000003038         Sft2d2         17.101         4.096    0.0020
  ENSRNOG00000007720         F1LX97_RAT     13.841         3.791    0.0027
  ENSRNOG00000019014         Ndst1          12.657         3.662    0.0003
  ENSRNOG00000017434         Mgat3          12.364         3.628    0.0005
  ENSRNOG00000001656         Kcnj15         11.724         3.551    0.0028
  ENSRNOG00000021292         ---            11.449         3.517    0.0015
  ENSRNOG00000017078         Sepn1          11.107         3.473    0.0011
  ENSRNOG00000030121         Enpep          10.970         3.456    0.0029
  ENSRNOG00000005854         Angpt1         10.920         3.449    0.0165
  ENSRNOG00000009944         LOC314407      10.858         3.441    0.0017
  ENSRNOG00000013279         Scd            10.775         3.430    0.0012
  ENSRNOG00000001724         LOC678704      10.690         3.418    0.0011
  ENSRNOG00000002463         LOC682752      10.633         3.411    0.0033
  ENSRNOG00000011630         Ak3l1          10.304         3.365    0.0441
  ENSRNOG00000005447         RGD1311564     10.117         3.339    0.0026
  ENSRNOG00000009019         Slc6a6         10.090         3.335    0.0016
  ENSRNOG00000002969         Itpkb          9.892          3.306    0.0020
  ENSRNOG00000037307         Spata22        9.876          3.304    0.0036
  ENSRNOG00000039717         Ipo11          9.584          3.261    0.0069
  ENSRNOG00000025372         Glce           9.536          3.253    0.0023
  ENSRNOG00000037884         Oxgr1          9.510          3.249    0.0169
  ENSRNOG00000021203         Atl3           9.487          3.246    0.0056
  ENSRNOG00000006787         Dhcr24         9.328          3.222    0.0023
  ENSRNOG00000015038         Adam10         9.279          3.214    0.0005
  ENSRNOG00000002519         Magt1          9.253          3.210    0.0010
  ENSRNOG00000038933         D3ZF12_RAT     9.225          3.206    0.0023
  ENSRNOG00000024757         RGD1310444     9.119          3.189    0.0066
  ENSRNOG00000030285         Epha3          9.064          3.180    0.0032
  ENSRNOG00000018338         Vwa1           9.017          3.173    0.0355
  ENSRNOG00000022802         Tmem184b       8.982          3.167    0.0070
  ENSRNOG00000013265         Tgfbr2         8.947          3.161    0.0014
  ENSRNOG00000026941         Tril           8.934          3.159    0.0024
  ENSRNOG00000020532         Kcnq1          8.904          3.154    0.0441
  ENSRNOG00000018503         LOC293190      8.862          3.148    0.0172
  ENSRNOG00000002198         LOC685352      8.711          3.123    0.0037
  ENSRNOG00000017172         Fam125b        8.706          3.122    0.0291
  ENSRNOG00000018554         ---            8.663          3.115    0.0067
  ENSRNOG00000013963         IL6RB_RAT      8.571          3.099    0.0023
  ENSRNOG00000042565         ---            8.547          3.095    0.0114
  ENSRNOG00000032834         Hspa13         8.544          3.095    0.0011
  ENSRNOG00000002355         Slc47a1        8.474          3.083    0.0025
  ENSRNOG00000011927         SDC3_RAT       8.460          3.081    0.0065
  ENSRNOG00000042540         Mef2a          8.454          3.080    0.0368
  ENSRNOG00000029216         Dgcr2          8.331          3.059    0.0175
  ENSRNOG00000023725         LOC689756      8.215          3.038    0.0191
  ENSRNOG00000028129         Fktn           8.207          3.037    0.0063
  ENSRNOG00000000547         Tspyl4         8.202          3.036    0.0103
  ENSRNOG00000011859         Eif5a2         8.192          3.034    0.0403
  ENSRNOG00000028387         E9PTK5_RAT     8.168          3.030    0.0197
  ENSRNOG00000015986         Rassf8         8.134          3.024    0.0094
  ENSRNOG00000029409         Gstm6l         8.062          3.011    0.0292
  ENSRNOG00000008895         Hnf4a          7.993          2.999    0.0398
  ENSRNOG00000038149         Defb9          7.948          2.991    0.0437
  ENSRNOG00000040287         Cyp1b1         7.890          2.980    0.0439
  ENSRNOG00000010468         Elovl6         7.871          2.977    0.0394
  ENSRNOG00000014524         F1M9D3_RAT     7.828          2.969    0.0077
  ENSRNOG00000014209         Utp6           7.793          2.962    0.0050
  ENSRNOG00000013419         Agphd1         7.789          2.961    0.0031
  ENSRNOG00000020653         S1pr2          7.775          2.959    0.0313
  ENSRNOG00000018714         Arl5b          7.770          2.958    0.0078
  ENSRNOG00000002408         Rbm47          7.719          2.948    0.0057
  ENSRNOG00000008971         Hnf4g          7.715          2.948    0.0085
  ENSRNOG00000011271         Mcc            7.688          2.943    0.0120
  ENSRNOG00000002276         LOC100359714   7.641          2.934    0.0073
  ENSRNOG00000009446         Rxra           7.607          2.927    0.0066
  ENSRNOG00000019400         Dag1           7.591          2.924    0.0010
  ENSRNOG00000013098         F1M9J1_RAT     7.581          2.922    0.0320
  ENSRNOG00000014511         Alg10          7.551          2.917    0.0076
  ENSRNOG00000012490         Amph           7.533          2.913    0.0461
  ENSRNOG00000014934         Fam63b         7.481          2.903    0.0193
  ENSRNOG00000039630         LOC290577      7.414          2.890    0.0045
  ENSRNOG00000032707         Egf            7.368          2.881    0.0017
  ENSRNOG00000015605         Ptprk          7.357          2.879    0.0298
  ENSRNOG00000000168         Gatm           7.311          2.870    0.0017
  ENSRNOG00000027097         F1M683_RAT     7.273          2.863    0.0087
  ENSRNOG00000018109         Clic4          7.251          2.858    0.0048
  ENSRNOG00000008629         Secisbp2l      7.236          2.855    0.0042
  ENSRNOG00000019799         Pcdhgc3        7.231          2.854    0.0246
  ENSRNOG00000024089         Fndc3b         7.221          2.852    0.0065
  ENSRNOG00000015852         D4AD82_RAT     7.192          2.846    0.0020
  ENSRNOG00000006967         Xiap           7.151          2.838    0.0136
  ENSRNOG00000031487         F1LM52_RAT     7.129          2.834    0.0477
  ENSRNOG00000014866         Pign           7.077          2.823    0.0190
  ENSRNOG00000033206         Entpd5         7.060          2.820    0.0070
  ENSRNOG00000037753         Slc10a2        7.002          2.808    0.0089
  ENSRNOG00000040195         F1LZT0_RAT     7.001          2.808    0.0018
  ENSRNOG00000042817         D4A5M8_RAT     6.925          2.792    0.0104
  ENSRNOG00000005070         Spopl          6.920          2.791    0.0139
  ENSRNOG00000006459         D4AEA4_RAT     6.871          2.781    0.0251
  ENSRNOG00000012784         Gtf3c4         6.850          2.776    0.0096
  ENSRNOG00000016968         Gramd4         6.838          2.774    0.0216
  ENSRNOG00000004448         RGD1307051     6.819          2.770    0.0050
  ENSRNOG00000021809         Gpx3           6.801          2.766    0.0008
  ENSRNOG00000014183         Gnaq           6.801          2.766    0.0084
  ENSRNOG00000012991         LOC100363275   6.798          2.765    0.0046
  ENSRNOG00000013443         Tm9sf3         6.791          2.764    0.0040
  ENSRNOG00000042673         LOC100359544   6.789          2.763    0.0012
  ENSRNOG00000003873         Cpd            6.767          2.758    0.0028
  ENSRNOG00000007990         Adipor2        6.762          2.758    0.0026
  ENSRNOG00000007804         C1galt1        6.762          2.757    0.0109
  ENSRNOG00000043256         D3ZNR8_RAT     6.720          2.749    0.0145
  ENSRNOG00000015124         Gpam           6.720          2.748    0.0109
  ENSRNOG00000004888         Spred2         6.690          2.742    0.0454
  ENSRNOG00000003960         Tmem27         6.682          2.740    0.0026
  ENSRNOG00000015750         Wnt7b          6.654          2.734    0.0218
  ENSRNOG00000030763         Dpp4           6.601          2.723    0.0011
  ENSRNOG00000039504         Q5M885_RAT     6.562          2.714    0.0116
  ENSRNOG00000032768         D3Z9G8_RAT     6.497          2.700    0.0214
  ENSRNOG00000039771         LOC100361629   6.494          2.699    0.0140
  ENSRNOG00000009274         Fut11          6.475          2.695    0.0354
  ENSRNOG00000027938         RGD1562037     6.420          2.683    0.0117
  ENSRNOG00000001335         Zkscan1        6.419          2.682    0.0077
  ENSRNOG00000004978         Prkacb         6.379          2.673    0.0216
  ENSRNOG00000005446         Gna11          6.363          2.670    0.0172
  ENSRNOG00000003884         Acmsd          6.362          2.669    0.0262
  ENSRNOG00000028190         D4ACF8_RAT     6.354          2.668    0.0432
  ENSRNOG00000006338         Lrp6           6.351          2.667    0.0041
  ENSRNOG00000009523         Rab11fip2      6.345          2.666    0.0470
  ENSRNOG00000003759         Galc           6.345          2.666    0.0140
  ENSRNOG00000010620         NDC1_RAT       6.319          2.660    0.0275
  ENSRNOG00000001821         Adipoq         6.306          2.657    0.0244
  ENSRNOG00000038572         RGD1562646     6.293          2.654    0.0106
  ENSRNOG00000026120         Fam8a1         6.282          2.651    0.0129
  ENSRNOG00000025476         RGD1359349     6.243          2.642    0.0126
  ENSRNOG00000019508         Wars2          6.216          2.636    0.0317
  ENSRNOG00000008271         Fam91a1        6.216          2.636    0.0031
  ENSRNOG00000017120         Abhd2          6.208          2.634    0.0278
  ENSRNOG00000010843         Nhlrc3         6.203          2.633    0.0255
  ENSRNOG00000030704         F1LV74_RAT     6.139          2.618    0.0369
  ENSRNOG00000002509         Gnl3l          6.129          2.616    0.0124
  ENSRNOG00000010841         Col8a2         6.089          2.606    0.0457
  ENSRNOG00000002728         Btc            6.088          2.606    0.0348
  ENSRNOG00000027320         Eif2c1         6.082          2.605    0.0243
  ENSRNOG00000009453         Mobkl2b        6.072          2.602    0.0271
  ENSRNOG00000007797         Rbpsuh         6.069          2.602    0.0133
  ENSRNOG00000017286         HYES_RAT       6.064          2.600    0.0032
  ENSRNOG00000002461         Nid1           6.057          2.599    0.0014
  ENSRNOG00000006649         Thrb           6.048          2.596    0.0180
  ENSRNOG00000025042         Pde3a          6.048          2.596    0.0189
  ENSRNOG00000015916         Ttc38          6.048          2.596    0.0384
  ENSRNOG00000013581         Extl3          6.038          2.594    0.0093
  ENSRNOG00000002332         MSPD1_RAT      6.034          2.593    0.0213
  ENSRNOG00000032757         D3Z903_RAT     6.032          2.593    0.0431
  ENSRNOG00000029651         Rdh2           6.025          2.591    0.0258
  ENSRNOG00000018588         Sox4           6.019          2.590    0.0342
  ENSRNOG00000012428         Maf            6.005          2.586    0.0483
  ENSRNOG00000009506         Mre11a         6.005          2.586    0.0332
  ENSRNOG00000028330         ---            5.987          2.582    0.0375
  ENSRNOG00000034025         D4A4T5_RAT     5.979          2.580    0.0227
  ENSRNOG00000007079         Met            5.979          2.580    0.0117
  ENSRNOG00000008088         Btbd3          5.979          2.580    0.0181
  ENSRNOG00000017546         Mylk3          5.945          2.572    0.0224
  ENSRNOG00000042333         Dnal1          5.895          2.559    0.0187
  ENSRNOG00000001092         Kl             5.873          2.554    0.0106
  ENSRNOG00000016498         ---            5.836          2.545    0.0049
  ENSRNOG00000037765         Lims1          5.833          2.544    0.0367
  ENSRNOG00000010267         Klhdc10        5.827          2.543    0.0346
  ENSRNOG00000043277         D3ZIC7_RAT     5.809          2.538    0.0206
  ENSRNOG00000024799         D3ZNV9_RAT     5.803          2.537    0.0032
  ENSRNOG00000004919         Gns            5.795          2.535    0.0282
  ENSRNOG00000015080         Wdfy1          5.766          2.528    0.0292
  ENSRNOG00000009565         Pdk4           5.764          2.527    0.0206
  ENSRNOG00000013082         LCAP_RAT       5.754          2.525    0.0322
  ENSRNOG00000026501         Slc6a19        5.742          2.522    0.0406
  ENSRNOG00000009597         Cyp4a1         5.740          2.521    0.0123
  ENSRNOG00000011560         Mtmr9          5.738          2.521    0.0368
  ENSRNOG00000022710         Prrg4          5.736          2.520    0.0269
  ENSRNOG00000013469         LOC100362805   5.715          2.515    0.0059
  ENSRNOG00000024640         RGD1304731     5.698          2.510    0.0080
  ENSRNOG00000018952         Sema3g         5.692          2.509    0.0143
  ENSRNOG00000020011         Q66HF5_RAT     5.677          2.505    0.0381
  ENSRNOG00000012826         Creb3l2        5.665          2.502    0.0189
  ENSRNOG00000032492         Usp22          5.657          2.500    0.0107
  ENSRNOG00000021840         LOC500046      5.644          2.497    0.0118
  ENSRNOG00000034026         Lclat1         5.642          2.496    0.0223
  ENSRNOG00000009153         Cidec          5.642          2.496    0.0432
  ENSRNOG00000028899         Zbtb33         5.633          2.494    0.0168
  ENSRNOG00000001766         Tfrc           5.613          2.489    0.0102
  ENSRNOG00000017901         Acy3           5.613          2.489    0.0044
  ENSRNOG00000012095         Pkia           5.596          2.484    0.0339
  ENSRNOG00000001796         Dgkg           5.573          2.479    0.0471
  ENSRNOG00000004958         RGD1304605     5.563          2.476    0.0100
  ENSRNOG00000025587         Plagl1         5.550          2.472    0.0289
  ENSRNOG00000027540         Fam102b        5.536          2.469    0.0410
  ENSRNOG00000001518         Itga6          5.519          2.465    0.0452
  ENSRNOG00000032723         Eftud1         5.515          2.463    0.0336
  ENSRNOG00000002053         F1M3H3_RAT     5.491          2.457    0.0081
  ENSRNOG00000003472         Atp11c-ps1     5.473          2.452    0.0317
  ENSRNOG00000003984         Apln           5.448          2.446    0.0337
  ENSRNOG00000012453         RGD1564560     5.438          2.443    0.0046
  ENSRNOG00000017846         Slc44a1        5.422          2.439    0.0293
  ENSRNOG00000016921         Klhl11         5.418          2.438    0.0275
  ENSRNOG00000026415         D4A301_RAT     5.403          2.434    0.0280
  ENSRNOG00000013798         Fnbp1l         5.391          2.431    0.0098
  ENSRNOG00000003620         Fmo3           5.384          2.429    0.0050
  ENSRNOG00000018220         Pde4dip        5.377          2.427    0.0462
  ENSRNOG00000000145         Pik3r3         5.352          2.420    0.0210
  ENSRNOG00000008834         LOC306096      5.351          2.420    0.0356
  ENSRNOG00000025882         Nipal1         5.345          2.418    0.0306
  ENSRNOG00000010996         Mobkl1a        5.341          2.417    0.0147
  ENSRNOG00000001582         Bach1          5.339          2.417    0.0199
  ENSRNOG00000022309         D3ZRU8_RAT     5.313          2.410    0.0048
  ENSRNOG00000015741         Slc2a13        5.298          2.406    0.0371
  ENSRNOG00000014303         F1M753_RAT     5.294          2.404    0.0391
  ENSRNOG00000036798         Dusp3          5.284          2.402    0.0199
  ENSRNOG00000012142         Glyat          5.283          2.401    0.0081
  ENSRNOG00000024426         D3ZXW1_RAT     5.259          2.395    0.0477
  ENSRNOG00000006628         Dusp16         5.256          2.394    0.0271
  ENSRNOG00000026143         Ckap2l         5.230          2.387    0.0271
  ENSRNOG00000018867         Klhdc7a        5.223          2.385    0.0489
  ENSRNOG00000025296         Lrrc8a         5.203          2.379    0.0176
  ENSRNOG00000014508         Mgll           5.203          2.379    0.0137
  ENSRNOG00000000589         RGD1310495     5.199          2.378    0.0372
  ENSRNOG00000014234         Hif1an         5.192          2.376    0.0394
  ENSRNOG00000008450         LOC100359539   5.178          2.372    0.0409
  ENSRNOG00000010744         Nrp1           5.177          2.372    0.0072
  ENSRNOG00000039837         RGD1563945     5.161          2.368    0.0466
  ENSRNOG00000013177         Map3k1         5.154          2.366    0.0114
  ENSRNOG00000021719         F1LX81_RAT     5.153          2.365    0.0133
  ENSRNOG00000024629         Hadha          5.116          2.355    0.0126
  ENSRNOG00000014907         Aldh8a1        5.105          2.352    0.0055
  ENSRNOG00000036673         Sectm1b        5.098          2.350    0.0121
  ENSRNOG00000024794         Senp5          5.096          2.349    0.0264
  ENSRNOG00000005131         Lin7c          5.086          2.347    0.0289
  ENSRNOG00000002225         Scarb2         5.081          2.345    0.0116
  ENSRNOG00000020284         Prkar2a        5.077          2.344    0.0215
  ENSRNOG00000014648         Efnb2          5.072          2.343    0.0303
  ENSRNOG00000002488         Galnt10        5.063          2.340    0.0437
  ENSRNOG00000017406         Atrnl1         5.056          2.338    0.0269
  ENSRNOG00000010813         Tspan14        5.048          2.336    0.0304
  ENSRNOG00000000645         Reep3          5.047          2.336    0.0262
  ENSRNOG00000018873         Fam168a        5.036          2.332    0.0160
  ENSRNOG00000020253         RAB1B_RAT      5.030          2.331    0.0128
  ENSRNOG00000001235         Gna12          5.012          2.325    0.0149
  ENSRNOG00000040215         F1LZL1_RAT     5.011          2.325    0.0302
  ENSRNOG00000011619         Myo9a          4.988          2.319    0.0163
  ENSRNOG00000039976         D3ZHG3_RAT     4.983          2.317    0.0137
  ENSRNOG00000016011         Plekhg1        4.971          2.314    0.0315
  ENSRNOG00000037909         Ppm1f          4.964          2.312    0.0269
  ENSRNOG00000016419         Pdlim5         4.962          2.311    0.0248
  ENSRNOG00000023280         Als2           4.952          2.308    0.0166
  ENSRNOG00000005417         Zhx2           4.948          2.307    0.0430
  ENSRNOG00000017671         Rasa3          4.944          2.306    0.0403
  ENSRNOG00000016848         Fzd4           4.942          2.305    0.0255
  ENSRNOG00000003508         LOC100364400   4.942          2.305    0.0244
  ENSRNOG00000012394         Bcl2l13        4.931          2.302    0.0466
  ENSRNOG00000018400         D4AEL2_RAT     4.931          2.302    0.0303
  ENSRNOG00000013707         Spata13        4.930          2.302    0.0445
  ENSRNOG00000002039         LOC100360066   4.930          2.301    0.0436
  ENSRNOG00000004563         Sec24a         4.917          2.298    0.0191
  ENSRNOG00000020386         D3ZKH4_RAT     4.906          2.295    0.0098
  ENSRNOG00000007419         Pank3          4.900          2.293    0.0128
  ENSRNOG00000024533         Aer61          4.889          2.290    0.0382
  ENSRNOG00000027151         Lrrc58         4.886          2.289    0.0393
  ENSRNOG00000030124         Ptpn11         4.869          2.284    0.0160
  ENSRNOG00000006131         Mettl2         4.846          2.277    0.0271
  ENSRNOG00000000407         Dcbld1         4.834          2.273    0.0412
  ENSRNOG00000008061         Nuak1          4.826          2.271    0.0360
  ENSRNOG00000037514         Qser1          4.821          2.269    0.0136
  ENSRNOG00000004959         Actr2          4.807          2.265    0.0327
  ENSRNOG00000028582         F1M163_RAT     4.795          2.261    0.0045
  ENSRNOG00000043037         LOC100366023   4.788          2.259    0.0349
  ENSRNOG00000012135         F1M2H7_RAT     4.763          2.252    0.0406
  ENSRNOG00000031069         D4A9A7_RAT     4.749          2.247    0.0462
  ENSRNOG00000023109         F1LVL2_RAT     4.736          2.244    0.0482
  ENSRNOG00000004442         RGD1311756     4.729          2.241    0.0456
  ENSRNOG00000021318         Epas1          4.723          2.240    0.0138
  ENSRNOG00000018099         Itch           4.702          2.233    0.0383
  ENSRNOG00000038892         LOC686123      4.691          2.230    0.0268
  ENSRNOG00000000296         Aqp6           4.685          2.228    0.0310
  ENSRNOG00000014901         Uggt1          4.684          2.228    0.0168
  ENSRNOG00000019659         Aspa           4.680          2.227    0.0055
  ENSRNOG00000010450         D4ADY9_RAT     4.662          2.221    0.0220
  ENSRNOG00000011066         6-Mar          4.658          2.220    0.0264
  ENSRNOG00000013121         Mier3          4.647          2.216    0.0408
  ENSRNOG00000030894         Slco1a6        4.640          2.214    0.0068
  ENSRNOG00000004964         Erbb3          4.609          2.205    0.0351
  ENSRNOG00000014135         Rab11fip4      4.607          2.204    0.0453
  ENSRNOG00000005052         Slc39a9        4.594          2.200    0.0454
  ENSRNOG00000005276         Csnk2a1        4.589          2.198    0.0259
  ENSRNOG00000015007         RGD1565591     4.583          2.196    0.0462
  ENSRNOG00000002099         Wdfy3          4.579          2.195    0.0217
  ENSRNOG00000001747         Pak2           4.572          2.193    0.0178
  ENSRNOG00000018226         Zcchc14        4.565          2.190    0.0441
  ENSRNOG00000010702         Ube3c          4.564          2.190    0.0154
  ENSRNOG00000010610         Hpgd           4.556          2.188    0.0125
  ENSRNOG00000001756         D3ZDR3_RAT     4.551          2.186    0.0486
  ENSRNOG00000006335         Klhl9          4.550          2.186    0.0083
  ENSRNOG00000016715         Kif11          4.547          2.185    0.0159
  ENSRNOG00000021916         Slc16a12       4.541          2.183    0.0224
  ENSRNOG00000011250         Inmt           4.506          2.172    0.0125
  ENSRNOG00000013140         Pdzd2          4.502          2.171    0.0305
  ENSRNOG00000012440         Msra           4.501          2.170    0.0308
  ENSRNOG00000019932         Ip6k1          4.500          2.170    0.0307
  ENSRNOG00000037227         Yes1           4.499          2.170    0.0412
  ENSRNOG00000012054         Zmpste24       4.498          2.169    0.0179
  ENSRNOG00000007370         Rnf144a        4.493          2.168    0.0443
  ENSRNOG00000022968         F1M4Y9_RAT     4.491          2.167    0.0400
  ENSRNOG00000011340         D3ZMJ4_RAT     4.488          2.166    0.0143
  ENSRNOG00000021705         D3ZXN6_RAT     4.486          2.165    0.0229
  ENSRNOG00000003865         Tmigd1         4.483          2.164    0.0072
  ENSRNOG00000012105         F1MAE3_RAT     4.478          2.163    0.0346
  ENSRNOG00000011312         F1LQ39_RAT     4.475          2.162    0.0366
  ENSRNOG00000000127         F1LT58_RAT     4.463          2.158    0.0484
  ENSRNOG00000022929         MTMRC_RAT      4.438          2.150    0.0307
  ENSRNOG00000033372         Klhl24         4.431          2.148    0.0197
  ENSRNOG00000008332         Smo            4.420          2.144    0.0209
  ENSRNOG00000028616         Pck1           4.418          2.143    0.0219
  ENSRNOG00000013281         Mib1           4.415          2.142    0.0306
  ENSRNOG00000011448         Eri1           4.410          2.141    0.0414
  ENSRNOG00000028422         Rmnd5a         4.409          2.141    0.0212
  ENSRNOG00000014859         Rnf152         4.404          2.139    0.0298
  ENSRNOG00000001893         LOC100362453   4.397          2.137    0.0349
  ENSRNOG00000018123         Ccny           4.396          2.136    0.0173
  ENSRNOG00000016337         Slc22a1        4.394          2.135    0.0356
  ENSRNOG00000003709         Kmo            4.389          2.134    0.0166
  ENSRNOG00000019939         CCND2_RAT      4.386          2.133    0.0383
  ENSRNOG00000029947         ---            4.377          2.130    0.0399
  ENSRNOG00000008346         Itgb6          4.372          2.128    0.0245
  ENSRNOG00000008678         Antxr1         4.357          2.123    0.0237
  ENSRNOG00000029924         Klk1l          4.344          2.119    0.0267
  ENSRNOG00000043406         LOC100360800   4.341          2.118    0.0323
  ENSRNOG00000012343         Pdp2           4.324          2.112    0.0419
  ENSRNOG00000009899         D3ZWL1_RAT     4.306          2.106    0.0427
  ENSRNOG00000003434         Trove2         4.301          2.105    0.0368
  ENSRNOG00000015519         Ces1d          4.294          2.102    0.0253
  ENSRNOG00000017439         Cgnl1          4.294          2.102    0.0236
  ENSRNOG00000014700         Ttc36          4.287          2.100    0.0266
  ENSRNOG00000007944         Edem1          4.281          2.098    0.0367
  ENSRNOG00000031263         Haao           4.246          2.086    0.0200
  ENSRNOG00000001647         Ets2           4.245          2.086    0.0357
  ENSRNOG00000008652         RGD1564964     4.226          2.079    0.0153
  ENSRNOG00000023202         Usp15          4.217          2.076    0.0230
  ENSRNOG00000016289         Bmpr1b         4.212          2.075    0.0370
  ENSRNOG00000015024         E9PT54_RAT     4.208          2.073    0.0252
  ENSRNOG00000000555         Eif4ebp2       4.199          2.070    0.0381
  ENSRNOG00000008620         Smad3          4.198          2.070    0.0440
  ENSRNOG00000008619         Agtrap         4.198          2.070    0.0217
  ENSRNOG00000009711         Hepacam2       4.196          2.069    0.0409
  ENSRNOG00000015734         Ube3a          4.193          2.068    0.0225
  ENSRNOG00000015634         SMAD4_RAT      4.189          2.067    0.0277
  ENSRNOG00000042519         RGD1312026     4.182          2.064    0.0380
  ENSRNOG00000007564         Evc            4.160          2.057    0.0289
  ENSRNOG00000008372         Vamp7          4.160          2.057    0.0433
  ENSRNOG00000024671         D4AA13_RAT     4.157          2.056    0.0120
  ENSRNOG00000004622         Calcrl         4.142          2.050    0.0131
  ENSRNOG00000009660         Enpp6          4.140          2.050    0.0247
  ENSRNOG00000014750         D3ZXU7_RAT     4.138          2.049    0.0176
  ENSRNOG00000008694         Miox           4.134          2.048    0.0226
  ENSRNOG00000004831         Arid2          4.134          2.047    0.0317
  ENSRNOG00000043167         Itga9          4.124          2.044    0.0349
  ENSRNOG00000001770         Ehhadh         4.114          2.040    0.0104
  ENSRNOG00000042160         Tmem167b       4.112          2.040    0.0466
  ENSRNOG00000018668         Glg1           4.095          2.034    0.0172
  ENSRNOG00000007985         D4ABH6_RAT     4.084          2.030    0.0231
  ENSRNOG00000014623         F1M3F2_RAT     4.071          2.026    0.0332
  ENSRNOG00000002227         Kit            4.056          2.020    0.0429
  ENSRNOG00000016219         Vnn1           4.052          2.019    0.0115
  ENSRNOG00000008322         E9PTI4_RAT     4.035          2.013    0.0418
  ENSRNOG00000011358         Hipk3          4.034          2.012    0.0372
  ENSRNOG00000028335         Fat4           4.017          2.006    0.0190
  ENSRNOG00000025554         Zfp445         4.009          2.003    0.0365
  ENSRNOG00000003388         Cenpf          3.990          1.996    0.0146
  ENSRNOG00000000614         Bicc1          3.987          1.995    0.0162
  ENSRNOG00000039091         D3ZRC4_RAT     3.975          1.991    0.0145
  ENSRNOG00000030154         Cyp4a2         3.962          1.986    0.0422
  ENSRNOG00000033172         ---            3.952          1.983    0.0176
  ENSRNOG00000017466         Kif5b          3.949          1.981    0.0128
  ENSRNOG00000042879         D4A3X0_RAT     3.943          1.979    0.0454
  ENSRNOG00000002146         Pkd2           3.942          1.979    0.0358
  ENSRNOG00000012940         Vps41          3.937          1.977    0.0280
  ENSRNOG00000017291         Sord           3.928          1.974    0.0133
  ENSRNOG00000001606         Adamts5        3.923          1.972    0.0420
  ENSRNOG00000016534         D3ZKX0_RAT     3.904          1.965    0.0295
  ENSRNOG00000007202         Sema3d         3.898          1.963    0.0254
  ENSRNOG00000012436         Adh6           3.897          1.962    0.0137
  ENSRNOG00000016334         Rod1           3.867          1.951    0.0167
  ENSRNOG00000018011         RGD1564456     3.867          1.951    0.0417
  ENSRNOG00000039494         D4A608_RAT     3.853          1.946    0.0328
  ENSRNOG00000014976         Acsm2          3.850          1.945    0.0330
  ENSRNOG00000006636         Otud6b         3.817          1.932    0.0439
  ENSRNOG00000015849         Sepp1          3.812          1.930    0.0292
  ENSRNOG00000004689         Ptdss1         3.811          1.930    0.0342
  ENSRNOG00000013808         Ces2g          3.803          1.927    0.0345
  ENSRNOG00000014673         Eri2           3.791          1.922    0.0429
  ENSRNOG00000009819         Vezf1          3.784          1.920    0.0450
  ENSRNOG00000016758         Loxl2          3.783          1.919    0.0310
  ENSRNOG00000010061         Gmfb           3.763          1.912    0.0466
  ENSRNOG00000023021         Msl2           3.746          1.906    0.0486
  ENSRNOG00000039571         Glod5          3.742          1.904    0.0370
  ENSRNOG00000017600         Ptpn9          3.739          1.903    0.0329
  ENSRNOG00000000590         Naglt1         3.718          1.895    0.0365
  ENSRNOG00000011511         Stk24          3.716          1.894    0.0398
  ENSRNOG00000018279         Sfxn1          3.712          1.892    0.0213
  ENSRNOG00000003953         RB3GP_RAT      3.709          1.891    0.0486
  ENSRNOG00000024632         Atf6           3.699          1.887    0.0421
  ENSRNOG00000016779         Fam120a        3.679          1.879    0.0257
  ENSRNOG00000010379         Cugbp1         3.670          1.876    0.0295
  ENSRNOG00000010780         Dlc1           3.664          1.874    0.0495
  ENSRNOG00000003948         Llgl1          3.659          1.871    0.0486
  ENSRNOG00000016183         Ipp            3.647          1.867    0.0466
  ENSRNOG00000017964         Slc22a25       3.567          1.835    0.0201
  ENSRNOG00000039745         Pm20d1         3.557          1.831    0.0300
  ENSRNOG00000010107         PALLD_RAT      3.528          1.819    0.0467
  ENSRNOG00000019444         D4ADJ6_RAT     3.515          1.814    0.0265
  ENSRNOG00000011260         Cmbl           3.513          1.813    0.0221
  ENSRNOG00000013322         DPOLA_RAT      3.505          1.810    0.0498
  ENSRNOG00000039278         Mcart1         3.477          1.798    0.0345
  ENSRNOG00000021108         Slc22a12       3.449          1.786    0.0263
  ENSRNOG00000010887         RGD1309534     3.435          1.781    0.0382
  ENSRNOG00000008331         RGD1309995     3.394          1.763    0.0425
  ENSRNOG00000007949         Rgn            3.355          1.746    0.0276
  ENSRNOG00000011987         Cd2ap          3.343          1.741    0.0306
  ENSRNOG00000042175         B6VQA7_RAT     3.331          1.736    0.0384
  ENSRNOG00000012190         Cldn2          3.324          1.733    0.0347
  ENSRNOG00000023972         F1M6Q3_RAT     3.323          1.733    0.0322
  ENSRNOG00000011763         Serp1          3.319          1.731    0.0316
  ENSRNOG00000004496         Rock2          3.318          1.730    0.0337
  ENSRNOG00000004677         Zeb2           3.306          1.725    0.0306
  ENSRNOG00000013409         Gclm           3.301          1.723    0.0338
  ENSRNOG00000004302         Pah            3.270          1.709    0.0368
  ENSRNOG00000010947         MMP14_RAT      3.253          1.702    0.0337
  ENSRNOG00000011058         Utrn           3.247          1.699    0.0378
  ENSRNOG00000018215         Slc22a6        3.246          1.698    0.0377
  ENSRNOG00000016456         Il33           3.234          1.693    0.0319
  ENSRNOG00000002541         Pds5a          3.164          1.662    0.0449
  ENSRNOG00000002680         Lamc1          3.139          1.650    0.0366
  ENSRNOG00000011124         Eif4g2-ps1     3.125          1.644    0.0380
  ENSRNOG00000004009         Xpnpep2        3.118          1.641    0.0414
  ENSRNOG00000010768         Kpna4          3.114          1.639    0.0499
  ENSRNOG00000042249         F1LTA7_RAT     3.101          1.633    0.0422
  ENSRNOG00000014166         Smoc2          3.078          1.622    0.0413
  ENSRNOG00000002305         Slc15a2        3.061          1.614    0.0400
  ENSRNOG00000005130         Ogdh           3.049          1.608    0.0465
  ENSRNOG00000018086         Slc22a8        3.048          1.608    0.0418
  ENSRNOG00000010814         Bmpr1a         3.006          1.588    0.0432
  ENSRNOG00000032885         CYC_RAT        2.936          1.554    0.0478
                                                                    
  Down-regulated Genes: 15                                          
  ENSRNOG00000032087         F1LWC2_RAT     0.301          −1.734   0.0328
  ENSRNOG00000032609         ---            0.300          −1.738   0.0394
  ENSRNOG00000033748         F1LWC2_RAT     0.299          −1.741   0.0381
  ENSRNOG00000025670         Shisa3         0.295          −1.759   0.0282
  ENSRNOG00000029115         ---            0.284          −1.815   0.0315
  ENSRNOG00000011821         S100a4         0.228          −2.134   0.0086
  ENSRNOG00000007632         Zmynd17        0.211          −2.243   0.0365
  ENSRNOG00000025408         D3ZTT0_RAT     0.189          −2.403   0.0422
  ENSRNOG00000028844         Slc9a5         0.181          −2.466   0.0282
  ENSRNOG00000006889         Ambp           0.150          −2.741   0.0177
  ENSRNOG00000028730         D3ZI71_RAT     0.148          −2.757   0.0450
  ENSRNOG00000026067         Wfdc10         0.144          −2.791   0.0123
  ENSRNOG00000037374         D3ZPQ1_RAT     0.140          −2.840   0.0087
  ENSRNOG00000033517         LOC100360791   0.129          −2.950   0.0009
  ENSRNOG00000042909         F1LZX4_RAT     0.107          −3.229   0.0466
  ENSRNOG00000014578         Fxyd4          0.096          −3.374   0.0001

[^1]: Academic Editor: Jean-Claude Lavoie
